0001437749-21-022776.txt : 20210928
0001437749-21-022776.hdr.sgml : 20210928
20210928162629
ACCESSION NUMBER: 0001437749-21-022776
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210927
FILED AS OF DATE: 20210928
DATE AS OF CHANGE: 20210928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berger Mark Stanley
CENTRAL INDEX KEY: 0001700283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38244
FILM NUMBER: 211287221
MAIL ADDRESS:
STREET 1: 140 RIVERSIDE DRIVE
STREET 2: APT. 9K
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genprex, Inc.
CENTRAL INDEX KEY: 0001595248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900772347
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
BUSINESS PHONE: 512-537-7997
MAIL ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
4
1
rdgdoc.xml
FORM 4
X0306
4
2021-09-27
0001595248
Genprex, Inc.
GNPX
0001700283
Berger Mark Stanley
3300 BEE CAVE ROAD
#650-227
AUSTIN
TX
78746
1
Chief Medical Officer
Stock Option (right to buy)
2.85
2021-09-27
4
A
0
550000
0
A
2022-09-27
2031-09-27
Common Stock
550000
550000
D
The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4).
One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant.
/s/ Ryan Confer as Attorney-In-Fact for Mark S. Berger
2021-09-28